Portal Biotech Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
34
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$47.4M
- Investors
-
14
Portal Biotech General Information
Description
Operator of a biotechnology company intended to develop biosensing technology. The company utilizes bioengineered nanopores to analyze single-cell proteins and metabolites with unparalleled precision, enabling life science markets to get alternatives for their critical unmet needs.
Contact Information
Website
www.portalbiotech.comCorporate Office
- Scale Space
- 58 Wood Lane
- London W12 7RZ
- England, United Kingdom
Corporate Office
- Scale Space
- 58 Wood Lane
- London W12 7RZ
- England, United Kingdom
Portal Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 30-Jun-2025 | $47.4M | Completed | Generating Revenue | ||
| 2. Early Stage VC | 15-Jul-2022 | Completed | Generating Revenue | |||
| 1. Seed Round | 16-Jul-2021 | $693K | $693K | Completed | Startup |
Portal Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 Preferred | ||||||||
| Series A1 Preferred | ||||||||
| B2 Ordinary | 67,366 | $0.001355 | $163.96 | $163.96 | 1x | $163.96 | 22.15% | |
| B Ordinary | 15,000 | $0.001355 | $45.16 | $45.16 | 1x | $45.16 | 4.93% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Portal Biotech Comparisons
Industry
Financing
Details
Portal Biotech Competitors (3)
One of Portal Biotech’s 3 competitors is Olink Proteomics, a Formerly PE-Backed company based in Uppsala, Sweden.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Olink Proteomics | Formerly PE-Backed | Uppsala, Sweden | ||||
| Nautilus Biotechnology | Formerly VC-backed | Seattle, WA | ||||
| Quantum-Si | Formerly VC-backed | Branford, CT |
Portal Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Portal Biotech Patents
Portal Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025265848-A1 | Nanopores and uses thereof for analysis of analytes | Pending | 30-Apr-2024 | ||
| WO-2025229321-A1 | Nanopores and uses thereof for analysis of analytes | Pending | 30-Apr-2024 | ||
| EP-4771383-A1 | Methods for nanopore-based analyte detection | Pending | 30-Aug-2023 | ||
| WO-2025046236-A1 | Methods for nanopore-based analyte detection | Inactive | 30-Aug-2023 | ||
| GB-202313202-D0 | Systems and methods for nanopore-based analyte detection | Inactive | 30-Aug-2023 | G01N33/48721 |
Portal Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Portal Biotech Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| British Business Bank | Lender/Debt Provider | Minority | ||
| Earlybird Venture Capital | Venture Capital | Minority | ||
| NATO Innovation Fund | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| We Venture Capital | Corporate Venture Capital | Minority |
Portal Biotech FAQs
-
When was Portal Biotech founded?
Portal Biotech was founded in 2021.
-
Where is Portal Biotech headquartered?
Portal Biotech is headquartered in London, United Kingdom.
-
What is the size of Portal Biotech?
Portal Biotech has 34 total employees.
-
What industry is Portal Biotech in?
Portal Biotech’s primary industry is Other Devices and Supplies.
-
Is Portal Biotech a private or public company?
Portal Biotech is a Private company.
-
What is the current valuation of Portal Biotech?
The current valuation of Portal Biotech is .
-
What is Portal Biotech’s current revenue?
The current revenue for Portal Biotech is .
-
How much funding has Portal Biotech raised over time?
Portal Biotech has raised $58M.
-
Who are Portal Biotech’s investors?
British Business Bank, Earlybird Venture Capital, NATO Innovation Fund, , and We Venture Capital are 5 of 14 investors who have invested in Portal Biotech.
-
Who are Portal Biotech’s competitors?
Olink Proteomics, Nautilus Biotechnology, and Quantum-Si are competitors of Portal Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
